Hydroxychloroquine appears to increase risk of mortality when used to treat COVID-19The largest study on the drug to date found that not only is there no benefit in treating COVID-19, but also a very consistent risk of harm 2020 Canadian hypertension guidelines now available, with separate guidelines for managing resistant casesProvide expert guidance on the prevention, diagnosis, risk assessment and treatment of hypertension in adults and children Kelly Grindrod named Canadian Pharmacist of the Year COVID-19 pandemic highlights University of Waterloo professor's innovative approach to pharmacist education Allerject voice-assisted epinephrine autoinjector back to Canadian market Second epinephrine autoinjector provides patients with an alternative to EpiPen in managing anaphylaxis BC allows 'safe supply' to patients with substance use disorders during COVID-19 With one health crisis piled on top of the other, healthcare advocates and policymakers worried COVID-19 would exacerbate the situation for at-risk patients PTSA advocates for immunization training CSHP invites techs to join Pharmacy Specialty Networks Health Canada makes temporary exemptions around opioid agonist treatment Techs can help tackle Lyme disease Pharmacy5in5 partners on COVID-19 quizzes First Previous 400 401 402 403 404 Next Last
